Catalent, Inc.
NYSE:CTLT
Overview | Financials
Company Name | Catalent, Inc. |
Symbol | CTLT |
Currency | USD |
Price | 58.69 |
Market Cap | 10,652,939,280 |
Dividend Yield | 0% |
52-week-range | 32.38 - 61.2 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Alessandro Maselli |
Website | https://www.catalent.com |
An error occurred while fetching data.
About Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD